Karl‐Martin Koch

577 total citations
9 papers, 460 citations indexed

About

Karl‐Martin Koch is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Karl‐Martin Koch has authored 9 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Karl‐Martin Koch's work include Renal Diseases and Glomerulopathies (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Dialysis and Renal Disease Management (3 papers). Karl‐Martin Koch is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Dialysis and Renal Disease Management (3 papers). Karl‐Martin Koch collaborates with scholars based in Germany and France. Karl‐Martin Koch's co-authors include Matthias B. Schulze, Michael Burg, R. Brunkhorst, Jürgen Floege, Stanley Shaldon, Tammo Ostendorf, Jörg Zwirner, Otto Götze, Charles A. Dinarello and Ralf Schindler and has published in prestigious journals such as The Journal of Physiology, Kidney International and Transplantation.

In The Last Decade

Karl‐Martin Koch

8 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl‐Martin Koch Germany	8	280	101	95	78	69	9	460
Emiko Fujita Japan	13	204 0.7×	95 0.9×	99 1.0×	69 0.9×	44 0.6×	18	418
Jens Gerth Germany	13	322 1.1×	102 1.0×	79 0.8×	104 1.3×	79 1.1×	33	657
Atsumi Harada Japan	15	242 0.9×	127 1.3×	43 0.5×	69 0.9×	71 1.0×	45	504
Roshni R. Molls United States	9	188 0.7×	88 0.9×	102 1.1×	49 0.6×	34 0.5×	9	452
Christine M. Logar United States	8	246 0.9×	125 1.2×	53 0.6×	47 0.6×	45 0.7×	13	414
Rosanna Coppo Italy	12	171 0.6×	93 0.9×	50 0.5×	31 0.4×	28 0.4×	14	418
M.E. de Broe Belgium	11	118 0.4×	142 1.4×	67 0.7×	60 0.8×	36 0.5×	15	434
B S Ooi United States	15	166 0.6×	111 1.1×	142 1.5×	64 0.8×	51 0.7×	37	625
Kinga Musiał Poland	13	208 0.7×	117 1.2×	64 0.7×	53 0.7×	73 1.1×	59	488
Yasushi Koitabashi Japan	13	208 0.7×	79 0.8×	74 0.8×	106 1.4×	81 1.2×	23	434

Countries citing papers authored by Karl‐Martin Koch

Since Specialization

Citations

This map shows the geographic impact of Karl‐Martin Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Martin Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Martin Koch more than expected).

Fields of papers citing papers by Karl‐Martin Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐Martin Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Martin Koch. The network helps show where Karl‐Martin Koch may publish in the future.

Co-authorship network of co-authors of Karl‐Martin Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Karl‐Martin Koch. A scholar is included among the top collaborators of Karl‐Martin Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl‐Martin Koch. Karl‐Martin Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Koch, Karl‐Martin, et al.. (2015). Clinical Aspects of Dialysis-Related Amyloidosis. Contributions to nephrology. 112. 90–96.

2.

Canaan–Kühl, Sima, et al.. (1998). C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney International. 53(5). 1143–1151. 50 indexed citations

3.

Gwinner, Wilfried, et al.. (1998). Antioxidant‐oxidant balance in the glomerulus and proximal tubule of the rat kidney. The Journal of Physiology. 509(2). 599–606. 40 indexed citations

4.

Eitner, Frank, Ralf Westerhuis, Michael Burg, et al.. (1997). Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney International. 51(1). 69–78. 55 indexed citations

5.

Zwirner, Jörg, Michael Burg, Matthias B. Schulze, et al.. (1997). Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney International. 51(4). 1257–1264. 96 indexed citations

6.

Kliem, Volker, Michael Burg, Björn Nashan, et al.. (1997). Recurrent Immunoglobulin A Nephropathy After Renal Transplantation. Transplantation. 64(10). 1493–1496. 70 indexed citations

7.

Schindler, Ralf, Matthias B. Schulze, Martin Oppermann, et al.. (1993). Gene expression of interleukin-1β during hemodialysis. Kidney International. 43(3). 712–721. 90 indexed citations

8.

Olbricht, Christoph J., et al.. (1993). Glomerulonephritis Associated with Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report and Review of the Literature. The Nephron journals/Nephron journals. 64(1). 139–141. 21 indexed citations

9.

Floege, Jürgen, Wolfgang Burchert, Almuth Brandis, et al.. (1990). Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-β2-microglobulin. Kidney International. 38(6). 1169–1176. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact